المؤلفون: Piga A; Department of Clinical and Biological Sciences, Turin University, Regione Gonzole, 10, Orbassano, 10043 Turin, Italy., Longo F; Department of Clinical and Biological Sciences, Turin University, Turin, Italy., Gamberini MR; Thalassemia Unit, Arcispedale S. Anna, Ferrara, Italy., Voskaridou E; Thalassemia and Sickle Cell Center, Laiko General Hospital, Athens, Greece., Ricchi P; Malattie Rare Del Globulo Rosso, AORN Cardarelli, Naples, Italy., Caruso V; ARNAS Garibaldi, Catania, Italy., Pietrangelo A; CEMEF, Medicina 2, Modena, Italy., Zhang X; Formerly Acceleron Pharma, Cambridge, MA, USA., Shetty JK; Celgene International Sàrl, Bristol-Myers Squibb Company, Boudry, Switzerland., Attie KM; Formerly Acceleron Pharma, Cambridge, MA, USA., Tartaglione I; Università della Campania 'L. Vanvitelli', Naples, Italy.

المصدر: Therapeutic advances in hematology [Ther Adv Hematol] 2022 Dec 05; Vol. 13, pp. 20406207221134404. Date of Electronic Publication: 2022 Dec 05 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE